WebRaynaud's phenomenon (RP) is common in rheumatic diseases. In the setting of systemic sclerosis (SSc), it can be complicated by digital ischemia that includes ulceration and gangrene. Systemic adverse effects may preclude the use of oral or topical vasodilators for the treatment of RP and its compli … WebNov 17, 2024 · Raynaud’s is a vasoconstrictive condition, that is, it causes blood vessels to contract. Medications that treat Raynaud’s are vasodilators—they cause blood vessels to widen. The first-line medications for moderate to severe cases of Raynaud’s are calcium channel blockers such as nifedipine and amlodipine.
Raynaud Phenomenon Treatment & Management - Medscape
WebNov 23, 2024 · Raynaud's (ray-NOSE) disease causes some areas of the body — such as fingers and toes — to feel numb and cold in response to cold temperatures or stress. In … WebMar 3, 2024 · Raynaud’s phenomenon is a common condition characterized by vasospasm of the digital arteries and resulting cyanosis and redness. It often does not require pharmacologic management, but in some cases symptoms are severe and pharmacologic management is necessary. Calcium channel blockers are often used first-line, but in some … highway from eugene oregon to florence oregon
Raynaud’s Treatments & Medications SingleCare
WebFeb 9, 2024 · Topical nitrates may be beneficial for patients with primary ... [SMD] 0.70; P<0.0001), with subgroup analysis indicating a larger treatment effect for secondary … WebRaynaud phenomenon is commonly seen in the hands and feet, affecting up to 22% of women of childbearing age (21- to 50-year age group). 8 Although less common, Raynaud phenomenon involving the tongue also has been reported. 9 Women of childbearing age are at increased risk of developing Raynaud phenomenon because it is an exaggerated … WebOct 1, 2024 · A 2016 Cochrane review and meta-analysis of the use of calcium channel blockers to treat primary Raynaud phenomenon included 7 randomized controlled trials … small stuffed farm animals